Regular administration of low doses of LSD reduces anxiety symptoms in mice, research finds. The results suggest possible treatments for human anxiety.
While reports of lingering cognitive problems after recovery from COVID-19 are common, new research shows some cognitive and EEG changes persist up to 10 months later.
Press Release: QUVIVIQ (daridorexant) recommended for approval in Europe as a new treatment for adults with insomnia disorder finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Ad hoc announcement pursuant to Art. 53 LR Idorsia receives a positive opinion from the Committee for Medicinal Products for Human Use for QUVIVIQ (daridorexant) for the treatment of adult patients
Idorsia Ltd (SIX: IDIA) today announced the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA), adopted a positive opinion for the use of QUVIVIQ™ (daridorexant) as the first dual orexin receptor antagonist in the European Union (EU) for the t.